Lab business > Regulations

Senate committee recommends legalising mitochondrial donation

05 July, 2018 by Lauren Davis

Australian women at risk of having babies suffering severe mitochondrial disease may soon be able to have healthy children.


New science policy set to strengthen national security

09 May, 2018

The Australian Government has released its new national security science and technology policy agenda, aimed at strengthening Australia's national security.


Cayman Chemical MaxSpec Lipidomics Standards

26 April, 2018

Cayman Chemical's MaxSpec Lipidomics Standards help achieve the accuracy and reproducibility required by lipidomics research.


Call to better record patient-reported outcomes in clinical trials

08 February, 2018

Researchers have recommended changes to the guidelines used in clinical trials, in an effort to gain information about the impact on the quality of life of participating patients.


Australian Government permits medicinal cannabis exports

12 January, 2018

The Australian Government has announced that it will permit the export of medicinal cannabis products.


GSK and Novartis taken to court over 'misleading' pain relief products

07 December, 2017

The ACCC has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia and Novartis Consumer Health Australasia, alleging they made false or misleading representations in the marketing of Voltaren Osteo Gel and Emulgel pain relief products.


Lose the jargon, win the war — the fight against superbugs

15 November, 2017

University of Birmingham researchers have identified new mechanisms used by bacteria to resist antibiotics, just days after one of their number voiced her concern surrounding the EU and UK's action plans to fight antibiotic-resistant infections.


Asbestos reporting protocols

09 October, 2017 by Peter Keyte Technical Manager — Air, Environmental

Under the various guidelines that relate to asbestos there are numerous requirements, implicit and explicit, for laboratories reporting asbestos testing results.


Sirtex penalised for alleged continuous disclosure breach

22 September, 2017

Sirtex Medical has paid a penalty of $100,000 after the Australian Securities and Investments Commission issued an infringement notice for an alleged failure by the company to comply with its continuous disclosure obligations.


Do you work for a biological, chemical or veterinary laboratory?

22 March, 2017

Do you provide any testing, or aspects of testing, on human samples? If so, the TGA in vitro diagnostic (IVD) medical device regulatory framework could impact you.


Video: Are you GHS ready?

20 October, 2016 by Lauren Davis

As part of its Virtual Seminar Series, Safe Work Australia has released a short video which guides businesses through how to comply with the internationally agreed system for classifying and labelling chemicals.


Get GHS ready at a forum near you

04 April, 2016

Comcare is holding a series of Australia-wide forums focusing on the transition to the new international system of chemical labelling and classification.


The risky business of cell culture

07 October, 2015 by Lauren Davis

The process of cell culture is one which can be beneficial for modelling health and disease but is not without its risks — risks which many scientists are often willing to take.


Governments shouldn't be able to censor research results they don't like

20 July, 2015 by Kypros Kypri, University of Newcastle

Governments often impose legal conditions on such research that can subvert science and the public interest.


Global chemical classification system coming to Australia

20 April, 2015

The United Nations has updated the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - an internationally agreed system that aims to synchronise chemical labelling in order to optimise safety.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd